About iX Biopharma

iX Biopharma is an SGX listed specialty pharmaceutical company focused on the development and commercialisation of innovative therapies using its proprietary WaferiX® sublingual drug delivery platform. As the company enters its next phase of growth, it is executing a major strategic expansion into the United States, anchored by a landmark US$41 million development contract from the U.S. Department of Defense (DoD) to fund Phase 3 clinical development of Wafermine®, its patented sublingual ketamine wafer for acute pain. Backed by this contract, the company is scaling up its U.S. infrastructure and manufacturing footprint to accelerate production and commercial market entry to the United States.

The Role

The candidate will work closely with, and provide comprehensive analytical, drafting, and administrative support, directly to the CEO. 

Key responsibilities include:

• Supporting the CE...